DEPARTMENT OF HEALTH AND HUMAN SERVICES 
PUBLIC HEALTH SERVICE 
NATIONAL INSTITUTES OF HEALTH 
RECOMBINANT DNA ADVISORY COMMITTEE 
MINUTES OF meeting! 
SEPTEMBER 10-11, 1981 
The RecxDmbinant I3NA Advisory Conmdttee (RAC) was convened for its twenty- third 
meeting at 9:00 a.m. on September 10, 1981, in Conference Ttocm 6, Building 31C, 
National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20205. 
Ray Thornton (Chairman), President, Arkansas State TMiversity, presided. In 
accordance with Public Law 92-463, the meeting was open to the public fran 
9:00 a.m. to 4:05 p.m. on Septoitoer 10, and from 8:30 a.m. to adjournment at 
10:30 a.m. on September 11. The meeting was closed to the public from 4:05 p.m. 
to 5:50 p.m. on September 10 for the review of proposals involving proprietary 
information . 
Committee manbers present for all or part of the meeting were : 
Abdul Karim Ahmed; I>avid Baltimore; Kenneth Bems; Winston Brill; L. Albert 
Daloz; Nina Fedoroff; Riohard Goldstein; Jean Harris; King Holmes; Patrioia 
King; Arthur Landy; Werner Maas; James Mason; Gerard McGarrity; Robert McKinney; 
Robert Mitchell; Elena Nightingale; Ramon Pinon; Mark Saginor; John Scandalios; 
Pieter Wensink; and William J. Gartland, Jr., Executive Secretary. 
A Committee roster is attached. (Attachment I) 
The following ad hoc consultants to the Committee were present : 
Susan K. Gottesman, National Institutes of Health, and Norton Zinder, Rockefeller 
University. 
The following non-voting manbers and liaison representatives were present : 
Charlotte Bell, U.S, Department of Justice; Chia T. Chen, OSHA, U.S. Department 
of Labor; Timothy J. Henry, Food and Drug Administration; Herman Lewis, National 
Science Foundation; Henry Miller, Bureau of Drugs, FDA; Jane Shultz, Veterans 
^The RAC is advisory to the NIH, and its recommendations should not be considered 
as final and accepted. The Office of Recombinant ENA Activities should be con- 
sulted for NIH policy on specific issues. 
[ 192 ] 
